Evidence map›Paper›PMID 38734812›Full record

ArticlePediatric research2025

High frequency of MEFV disease-causing variants in children with very-early-onset inflammatory bowel disease.

Aasem Abu Shtaya, Naama Orenstein, Lily Bazak, Gabriel Lidzbarsky, Marina Lifshitc Kalis, Gil Amarilyo, Efrat Sofrin-Drucker, Ranit Jaron, Noa Ruhrman Shahar, Nesia Kropach Gilad and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Aasem Abu Shtaya *Recanati Genetic Institute, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel. aasemab@hotmail.com.
Naama Orenstein *Pediatric Genetics Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Lily BazakRecanati Genetic Institute, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel.
Gabriel LidzbarskyRecanati Genetic Institute, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel.
Marina Lifshitc KalisRecanati Genetic Institute, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel.
Gil AmarilyoSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Efrat Sofrin-DruckerPediatric Genetics Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Ranit JaronPediatric Genetics Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Noa Ruhrman ShaharRecanati Genetic Institute, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel.
Nesia Kropach GiladPediatric Genetics Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Lina Basel-SalmonRecanati Genetic Institute, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBiological similarities between inflammatory bowel disease (IBD) and familial Mediterranean fever (FMF) have been described in humans and animal models suggesting a possible common genetic basis. FMF is caused by variants in the MEFV gene which encodes pyrin, an immune regulator. This study aimed to investigate the carrier rate of disease-causing MEFV variants in children of different ethnicities diagnosed with very-early-onset IBD (VEO-IBD).

methodsThe study included 23 children diagnosed with VEO-IBD who had undergone whole exome sequencing. The exomes were evaluated for MEFV monoallelic and biallelic disease-causing variants and compared to exome sequencing data of 250 probands with suspected monogenic diseases other than IBD.

resultsOf the 23 children diagnosed with VEO-IBD, 12 (52%) were carriers of at least one MEFV disease-causing variant, which was threefold higher than in individuals without IBD. The most frequent variants identified were p.M694V and p.E148Q (42% each). The allelic frequency of MEFV variants was found to be higher across the VEO-IBD group in 13 of 14 ethnicities compared to the control group.

conclusionThe study suggests that disease-causing variants in the MEFV gene should be sought in cases of VEO-IBD. However, the clinical importance of this finding is yet to be defined. IMPACT: There are biological similarities between inflammatory bowel disease and familial Mediterranean fever, suggesting a possible genetic relationship. Children less than 6 years old clinically diagnosed with inflammatory bowel disease have a threefold higher rate of disease-causing variants in the MEFV gene than controls. Monogenic testing in children with very-early-onset inflammatory bowel disease should include a search for MEFV variants.

Indexed as

Familial Mediterranean FeverInflammatory Bowel DiseasesPyrinAge of OnsetCase-Control StudiesChildChild, PreschoolExome SequencingFemaleGene FrequencyGenetic Predisposition to DiseaseGenetic VariationHeterozygoteHumansInfantMaleMEFV protein, humanPyrin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.